Reply to the letter "Understanding lactate and its clearance during extracorporeal membrane oxygenation for supporting refractory cardiogenic shock patients"

BMC Cardiovasc Disord. 2023 May 12;23(1):250. doi: 10.1186/s12872-023-03273-0.

Abstract

This is a reply to the letter titled "Understanding lactate and its clearance during extracorporeal membrane oxygenation for supporting refractory cardiogenic shock patients" by Eva Rully Kurniawati et al. In response to the concerns raised about our paper published in BMC Cardiovascular Disorders, titled "Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study," we have addressed the confounding bias on the population included and the use of VA-ECMO and Impella CP. Furthermore, we have provided new data on the correlation of oxygen supply and lactate levels at admission of cardiogenic shock.

Publication types

  • Multicenter Study
  • Letter

MeSH terms

  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Hospital Mortality
  • Humans
  • Lactic Acid
  • Retrospective Studies
  • Shock, Cardiogenic* / diagnosis
  • Shock, Cardiogenic* / therapy

Substances

  • Lactic Acid